Hereditary Retinopathies : Progress in Development of Genetic and Molecular Therapies. 1st ed. 2012
- 種類:
- 電子ブック
- 責任表示:
- by Pete Humphries, Marian M. Humphries, Lawrence C. S. Tam, G. Jane Farrar, Paul F. Kenna, Matthew Campbell, Anna-Sophia Kiang
- 出版情報:
- New York, NY : Springer New York : Imprint: Springer, 2012
- 著者名:
Humphries, Pete. Humphries, Marian M. Tam, Lawrence C. S. Farrar, G. Jane. Kenna, Paul F. Campbell, Matthew. Kiang, Anna-Sophia. SpringerLink (Online service) - シリーズ名:
- SpringerBriefs in Genetics ; 1
- ISBN:
- 9781461444992 [1461444993]
- 注記:
- Preface -- Introduction -- Gene-based Medicines directly targeting genetic defects and molecular pathologies common to multiple forms of disease -- Molecular Medicines.
The hereditary retinopathy, retinitis pigmentosa (RP), which affects 1 in 3,500 people worldwide, is the most common cause of registered visual handicap among those of the working age in developed countries. RP is a highly variable disorder where patients may develop symptomatic visual loss in early childhood, while others may remain asymptomatic until mid-adulthood. Most cases of RP segregate in autosomal dominant, recessive or X-linked recessive modes, with approximately 41 genes being implicated in disease pathology to date (RetNet). The extensive genetic heterogeneity associated with autosomal dominant RP (adRP) is an undisputed hindrance to the development of genetically based therapeutics. - ローカル注記:
- 学内専用E-BOOKS (local access only)
類似資料:
Springer New York : Imprint: Springer |
Springer Netherlands : Imprint: Springer |
Springer Berlin Heidelberg : Imprint: Springer |
Springer Berlin Heidelberg |
American Association of Pharmaceutical Scientists |
Springer Berlin Heidelberg : Imprint: Springer |
Springer Basel : Imprint: Springer |
Springer Berlin Heidelberg : Imprint: Springer |
Springer New York : Imprint: Springer |
Springer New York : Imprint: Springer |
Springer New York : Imprint: Springer |
Springer Berlin Heidelberg : Imprint: Springer |